In a chance constrained program (CCP), decision makers seek the best decision whose probability of violating the uncertainty constraints is within the prespecified risk level. As a CCP is often nonconvex and is difficult to solve to optimality, much effort has been devoted to developing convex inner approximations for a CCP, among which the conditional value-at-risk (CVaR) has been known to be the best for more than a decade. This paper studies and generalizes the ALSO-X, originally proposed by Ahmed, Luedtke, SOng, and Xie in 2017 , for solving a CCP. We first show that the ALSO-X resembles a bilevel optimization, where the upper-level problem is to find the best objective function value and enforce the feasibility of a CCP for a given decision from the lower-level problem, and the lower-level problem is to minimize the expectation of constraint violations subject to the upper bound of the objective function value provided by the upper-level problem. This interpretation motivates us to prove that when uncertain constraints are convex in the decision variables, ALSO-X always outperforms the CVaR approximation. We further show (i) sufficient conditions under which ALSO-X can recover an optimal solution to a CCP; (ii) an equivalent bilinear programming formulation of a CCP, inspiring us to enhance ALSO-X with a convergent alternating minimization method (ALSO-X+); and (iii) an extension of ALSO-X and ALSO-X+ to distributionally robust chance constrained programs (DRCCPs) under the ∞−Wasserstein ambiguity set. Our numerical study demonstrates the effectiveness of the proposed methods.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.